Cheryl Gault
Operationeel Directeur bij Rapport Therapeutics, Inc.
Vermogen: 3 M $ op 31-05-2024
Profiel
Cheryl Gault is currently the Chief Operating Officer at Rapport Therapeutics, Inc. She previously worked as the Head of Sales & Marketing at Genzyme Corp.
From 2017 to 2019, she served as the VP of Commercial Strategy & New Product Planning at Ironwood Pharmaceuticals, Inc. Cheryl also held the position of Chief Operating Officer at Cyclerion Therapeutics, Inc. from 2021 to 2023.
She completed her undergraduate degree at Boston College.
Bekende belangen in openbare bedrijven
| Onderneming | Datum | Aantal aandelen | Totale waarde | Waarderingsdatum |
|---|---|---|---|---|
Rapport Therapeutics, Inc.
 Rapport Therapeutics, Inc. BiotechnologyHealth Technology Rapport Therapeutics, Inc. engages in the discovery and development of transformational small molecule medicines for patients suffering from central nervous system disorders. It develops the RAP (receptor associated proteins) technology platform. The company was founded by Steven M. Paul and David Bredt in February 2022 and is headquartered in Boston, MA. 0.45% | 06-06-2024 | 157 941 ( 0.45% ) | 3 M $ | 31-05-2024 |
Actieve functies van Cheryl Gault
| Bedrijven | Functie | Begin |
|---|---|---|
Rapport Therapeutics, Inc.
Rapport Therapeutics, Inc. BiotechnologyHealth Technology Rapport Therapeutics, Inc. engages in the discovery and development of transformational small molecule medicines for patients suffering from central nervous system disorders. It develops the RAP (receptor associated proteins) technology platform. The company was founded by Steven M. Paul and David Bredt in February 2022 and is headquartered in Boston, MA. | Operationeel Directeur | 07-09-2023 |
Eerdere bekende functies van Cheryl Gault
| Bedrijven | Functie | Einde |
|---|---|---|
| CYCLERION THERAPEUTICS, INC. | Operationeel Directeur | 28-07-2023 |
| IRONWOOD PHARMACEUTICALS, INC. | Corporate Officer/Principal | 01-04-2019 |
Genzyme Corp.
 Genzyme Corp. Medical SpecialtiesHealth Technology Genzyme Corp. engages in development and manufacture of specialty therapeutic, surgical and diagnostic product. It serves in the areas of rare genetic diseases, multiple sclerosis, cardiovascular diseases and endocrinology. The company was founded on June 8, 1981 and is headquartered in Cambridge, MA. | Verkoop & Marketing | - |
Opleiding van Cheryl Gault
| Boston College | Undergraduate Degree |
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
| Beursgenoteerde bedrijven | 3 |
|---|---|
| CYCLERION THERAPEUTICS, INC. | Health Technology |
| IRONWOOD PHARMACEUTICALS, INC. | Health Technology |
 | Health Technology |
| Bedrijven in privébezit | 1 |
|---|---|
Genzyme Corp.
Genzyme Corp. Medical SpecialtiesHealth Technology Genzyme Corp. engages in development and manufacture of specialty therapeutic, surgical and diagnostic product. It serves in the areas of rare genetic diseases, multiple sclerosis, cardiovascular diseases and endocrinology. The company was founded on June 8, 1981 and is headquartered in Cambridge, MA. | Health Technology |
